Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Small study explores ways to boost sexual wellness after breast cancer

NCT ID NCT07023822

Symptom relief Sponsor: The University of Tennessee, Knoxville Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether it's possible to test a program that combines different approaches to help breast cancer survivors with sexual health issues. 18 women who had finished their main cancer treatment took part. The goal was to see if women would join, stay, and follow the program, not to measure if it worked.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

18 people

The number who actually took part.

Started

Jun 2025

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Age ≥18 female 2. Ability to read and write English 3. History of any stage of breast cancer 4. Completed primary treatment (chemotherapy, radiation and/or surgery) ≥3 months and ≤ 10 years prior to registration. Participants may use concurrent adjuvant endocrine therapy or HER2-targeted therapy while on study. 5. Able to engage in sexual activity including penetration or insertion into the vagina 6. Currently has a sexual partner. 7. Responds "yes" to "Do you currently experience vaginal or vulvar dryness and/or discomfort/pain with sexual activity?" 8. Responds "yes" to at least one of the following questions: * "Have you experienced negative changes in your body image since being diagnosed or treated for cancer?" or * "Have you experienced negative changes in your sexual desire since being diagnosed or treated for cancer?" Exclusion Criteria: 1. Antidepressants are allowed if a person has been on them for 30 days prior to registration, and dose or treatment is not expected to change. 2. An active psychiatric disorder that is or causing you symptoms or distress, such as major depressive disorder, bipolar disorder, obsessive compulsive disorder, PTSD, schizophrenia or borderline personality disorder (Defined per medical history and/or patient self-report) 3. Currently enrolled in another study that addresses sexual health (enrollment in other clinical trials will be allowed). 4. Previous participant in WISH Study 5. Currently receiving active treatment 6. Use of oral, transdermal or vaginal estrogen 7. Allergy or intolerance to Replens, Hyalo Gyn or any of their components.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Body image are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm hypoactive sexual desire disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Body image Breast cancer Sexual desire disorder Vulvovaginal signs and symptoms

Contacts and locations

Locations

  • University of Tennessee, College of Nursing

    Knoxville, Tennessee, 37996, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.